In pancreatic ductal adenocarcinoma tissues, GATA1 was found to be highly expressed and an independent predictor of prognosis and response to gemcitabine therapy through the anti-apoptotic pathway [26]. The gene discussed is GATA1; the disease is pancreatic ductal adenocarcinoma.